Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis

The concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy (NAC) has been proposed to improve the pathologic complete response (pCR) rate, although there are conflicting views about its efficacy and safety. The purpose of this study was to evaluate the efficacy and cardiac sa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Clin Risk Manag
Main Authors: Wu, Yu-Tuan, Xu, Zhou, Zhang, Ke, Wu, Jiu-song, Li, Xin, Arshad, Bilal, Li, Ying-Cun, Wang, Zhong-Liang, Li, Hong-Yuan, Wu, Kai-Nan, Kong, Ling-Quan
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165855/
https://ncbi.nlm.nih.gov/pubmed/30310287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S176214
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados